LLY
NYSE Eli Lilly and Company$1,184.78 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1,184.78, $9.31 below the day’s high of $1,194.09
- YTD change
- +10.24%
- vs 20-day SMA
- +2.95%
- vs 200-day SMA
- +10.72%
Price ranges
Price & Performance
+298.15 (+33.63%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 8.3% away from all-time highs of $1,292.65
- LLY is up 10% since the beginning of the year
- LLY is up 64% over the past 12 months
- LLY is up 1% over the past 1 month
- 1% of all LLY investors are betting against LLY
- Number of investors short LLY has gone down 18% versus last month
LLY reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +63.1%.
- Previous minute
- -$0.04
- Last hour
- -$0.85
- Last 5 days
- +2.76%
- vs 8-day SMA
- +1.98%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.